nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—Estradiol valerate/Dienogest—prostate cancer	0.351	1	CrCtD
Nandrolone decanoate—AR—prostate cancer	0.0818	0.544	CbGaD
Nandrolone decanoate—CYP19A1—prostate cancer	0.0685	0.456	CbGaD
Nandrolone decanoate—AR—Nilutamide—prostate cancer	0.0575	0.315	CbGbCtD
Nandrolone decanoate—AR—Bicalutamide—prostate cancer	0.0575	0.315	CbGbCtD
Nandrolone decanoate—AR—Flutamide—prostate cancer	0.0476	0.261	CbGbCtD
Nandrolone decanoate—Estradiol valerate/Dienogest—Estrone—prostate cancer	0.0351	0.156	CrCrCtD
Nandrolone decanoate—Nandrolone phenpropionate—Estradiol valerate/Dienogest—prostate cancer	0.0299	0.132	CrCrCtD
Nandrolone decanoate—Estradiol valerate/Dienogest—Estradiol—prostate cancer	0.0266	0.118	CrCrCtD
Nandrolone decanoate—Estradiol valerate/Dienogest—Ethinyl Estradiol—prostate cancer	0.026	0.115	CrCrCtD
Nandrolone decanoate—Testosterone—Abiraterone—prostate cancer	0.0248	0.11	CrCrCtD
Nandrolone decanoate—AR—Estradiol—prostate cancer	0.0198	0.108	CbGbCtD
Nandrolone decanoate—Testosterone Propionate—Estradiol valerate/Dienogest—prostate cancer	0.014	0.062	CrCrCtD
Nandrolone decanoate—Etonogestrel—Ethinyl Estradiol—prostate cancer	0.0132	0.0585	CrCrCtD
Nandrolone decanoate—Norelgestromin—Ethinyl Estradiol—prostate cancer	0.0125	0.0554	CrCrCtD
Nandrolone decanoate—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.0103	0.0458	CrCrCtD
Nandrolone decanoate—Testosterone—Estramustine—prostate cancer	0.0103	0.0458	CrCrCtD
Nandrolone decanoate—Norethindrone—Ethinyl Estradiol—prostate cancer	0.00829	0.0368	CrCrCtD
Nandrolone decanoate—Testosterone—Estrone—prostate cancer	0.00819	0.0364	CrCrCtD
Nandrolone decanoate—Testosterone—Estradiol—prostate cancer	0.00621	0.0276	CrCrCtD
Nandrolone decanoate—Testicular atrophy—Nilutamide—prostate cancer	0.00274	0.0713	CcSEcCtD
Nandrolone decanoate—Testicular atrophy—Degarelix—prostate cancer	0.00245	0.0637	CcSEcCtD
Nandrolone decanoate—CYP19A1—semen—prostate cancer	0.00235	0.166	CbGeAlD
Nandrolone decanoate—AR—penis—prostate cancer	0.00219	0.154	CbGeAlD
Nandrolone decanoate—AR—semen—prostate cancer	0.00208	0.147	CbGeAlD
Nandrolone decanoate—Hoarseness—Estramustine—prostate cancer	0.00102	0.0265	CcSEcCtD
Nandrolone decanoate—Water retention—Conjugated Estrogens—prostate cancer	0.000872	0.0227	CcSEcCtD
Nandrolone decanoate—Hirsutism—Estrone—prostate cancer	0.000737	0.0192	CcSEcCtD
Nandrolone decanoate—Hirsutism—Estradiol valerate/Dienogest—prostate cancer	0.000643	0.0167	CcSEcCtD
Nandrolone decanoate—CYP19A1—prostate gland—prostate cancer	0.00059	0.0416	CbGeAlD
Nandrolone decanoate—MAOB—prostate gland—prostate cancer	0.000555	0.0391	CbGeAlD
Nandrolone decanoate—Dysphonia—Estramustine—prostate cancer	0.000545	0.0142	CcSEcCtD
Nandrolone decanoate—AR—prostate gland—prostate cancer	0.000522	0.0368	CbGeAlD
Nandrolone decanoate—Hirsutism—Bicalutamide—prostate cancer	0.000494	0.0128	CcSEcCtD
Nandrolone decanoate—MAOA—prostate gland—prostate cancer	0.000474	0.0334	CbGeAlD
Nandrolone decanoate—MAOB—seminal vesicle—prostate cancer	0.00047	0.0331	CbGeAlD
Nandrolone decanoate—Acne—Estradiol valerate/Dienogest—prostate cancer	0.000444	0.0115	CcSEcCtD
Nandrolone decanoate—AR—seminal vesicle—prostate cancer	0.000442	0.0311	CbGeAlD
Nandrolone decanoate—Local reaction—Ethinyl Estradiol—prostate cancer	0.000439	0.0114	CcSEcCtD
Nandrolone decanoate—Fluid retention—Abiraterone—prostate cancer	0.000413	0.0107	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Estramustine—prostate cancer	0.000401	0.0104	CcSEcCtD
Nandrolone decanoate—MAOA—seminal vesicle—prostate cancer	0.000401	0.0283	CbGeAlD
Nandrolone decanoate—Water retention—Prednisone—prostate cancer	0.000388	0.0101	CcSEcCtD
Nandrolone decanoate—AR—epithelium—prostate cancer	0.000384	0.0271	CbGeAlD
Nandrolone decanoate—MAOB—renal system—prostate cancer	0.000378	0.0267	CbGeAlD
Nandrolone decanoate—MAOB—urethra—prostate cancer	0.000372	0.0262	CbGeAlD
Nandrolone decanoate—Gynaecomastia—Nilutamide—prostate cancer	0.000356	0.00925	CcSEcCtD
Nandrolone decanoate—AR—renal system—prostate cancer	0.000356	0.0251	CbGeAlD
Nandrolone decanoate—Gynaecomastia—Flutamide—prostate cancer	0.000354	0.00921	CcSEcCtD
Nandrolone decanoate—Libido decreased—Estramustine—prostate cancer	0.000351	0.00912	CcSEcCtD
Nandrolone decanoate—AR—urethra—prostate cancer	0.00035	0.0247	CbGeAlD
Nandrolone decanoate—Hirsutism—Goserelin—prostate cancer	0.000344	0.00893	CcSEcCtD
Nandrolone decanoate—Hirsutism—Conjugated Estrogens—prostate cancer	0.000341	0.00885	CcSEcCtD
Nandrolone decanoate—Oligospermia—Epirubicin—prostate cancer	0.000328	0.00853	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Estramustine—prostate cancer	0.000323	0.00839	CcSEcCtD
Nandrolone decanoate—MAOA—renal system—prostate cancer	0.000323	0.0228	CbGeAlD
Nandrolone decanoate—Gynaecomastia—Degarelix—prostate cancer	0.000318	0.00826	CcSEcCtD
Nandrolone decanoate—MAOA—urethra—prostate cancer	0.000317	0.0224	CbGeAlD
Nandrolone decanoate—Libido decreased—Nilutamide—prostate cancer	0.000311	0.00809	CcSEcCtD
Nandrolone decanoate—Libido decreased—Flutamide—prostate cancer	0.00031	0.00806	CcSEcCtD
Nandrolone decanoate—Oligospermia—Doxorubicin—prostate cancer	0.000304	0.0079	CcSEcCtD
Nandrolone decanoate—Irritability—Estrone—prostate cancer	0.000297	0.00771	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Goserelin—prostate cancer	0.000293	0.00762	CcSEcCtD
Nandrolone decanoate—Libido decreased—Estradiol valerate/Dienogest—prostate cancer	0.000293	0.0076	CcSEcCtD
Nandrolone decanoate—Acne—Ethinyl Estradiol—prostate cancer	0.000289	0.0075	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Nilutamide—prostate cancer	0.000287	0.00745	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Flutamide—prostate cancer	0.000285	0.00741	CcSEcCtD
Nandrolone decanoate—Libido decreased—Degarelix—prostate cancer	0.000278	0.00723	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Goserelin—prostate cancer	0.000277	0.0072	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Ethinyl Estradiol—prostate cancer	0.000276	0.00718	CcSEcCtD
Nandrolone decanoate—Hirsutism—Estradiol—prostate cancer	0.000273	0.00708	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Estradiol valerate/Dienogest—prostate cancer	0.000269	0.007	CcSEcCtD
Nandrolone decanoate—Local reaction—Mitoxantrone—prostate cancer	0.000267	0.00693	CcSEcCtD
Nandrolone decanoate—CYP19A1—testis—prostate cancer	0.00026	0.0183	CbGeAlD
Nandrolone decanoate—Erectile dysfunction—Estramustine—prostate cancer	0.000259	0.00673	CcSEcCtD
Nandrolone decanoate—Irritability—Estradiol valerate/Dienogest—prostate cancer	0.000259	0.00673	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Bicalutamide—prostate cancer	0.000257	0.00668	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Degarelix—prostate cancer	0.000256	0.00665	CcSEcCtD
Nandrolone decanoate—Azoospermia—Epirubicin—prostate cancer	0.000256	0.00664	CcSEcCtD
Nandrolone decanoate—MAOB—testis—prostate cancer	0.000245	0.0172	CbGeAlD
Nandrolone decanoate—Acne—Goserelin—prostate cancer	0.000237	0.00617	CcSEcCtD
Nandrolone decanoate—Azoospermia—Doxorubicin—prostate cancer	0.000236	0.00614	CcSEcCtD
Nandrolone decanoate—Fluid retention—Ethinyl Estradiol—prostate cancer	0.00023	0.00599	CcSEcCtD
Nandrolone decanoate—AR—testis—prostate cancer	0.00023	0.0162	CbGeAlD
Nandrolone decanoate—Erectile dysfunction—Nilutamide—prostate cancer	0.00023	0.00597	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Flutamide—prostate cancer	0.000229	0.00595	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Goserelin—prostate cancer	0.000227	0.00591	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Conjugated Estrogens—prostate cancer	0.000225	0.00585	CcSEcCtD
Nandrolone decanoate—Libido decreased—Bicalutamide—prostate cancer	0.000225	0.00584	CcSEcCtD
Nandrolone decanoate—Hoarseness—Capecitabine—prostate cancer	0.000225	0.00584	CcSEcCtD
Nandrolone decanoate—Jaundice—Flutamide—prostate cancer	0.000216	0.00561	CcSEcCtD
Nandrolone decanoate—MAOA—testis—prostate cancer	0.000209	0.0147	CbGeAlD
Nandrolone decanoate—Disturbance in sexual arousal—Bicalutamide—prostate cancer	0.000207	0.00538	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Degarelix—prostate cancer	0.000205	0.00534	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Abiraterone—prostate cancer	0.000197	0.00512	CcSEcCtD
Nandrolone decanoate—Libido decreased—Ethinyl Estradiol—prostate cancer	0.00019	0.00494	CcSEcCtD
Nandrolone decanoate—CYP19A1—lymph node—prostate cancer	0.000188	0.0133	CbGeAlD
Nandrolone decanoate—Acne—Estradiol—prostate cancer	0.000188	0.00489	CcSEcCtD
Nandrolone decanoate—Fluid retention—Conjugated Estrogens—prostate cancer	0.000188	0.00488	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Estradiol—prostate cancer	0.00018	0.00468	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Goserelin—prostate cancer	0.000179	0.00465	CcSEcCtD
Nandrolone decanoate—MAOB—lymph node—prostate cancer	0.000177	0.0125	CbGeAlD
Nandrolone decanoate—Disturbance in sexual arousal—Ethinyl Estradiol—prostate cancer	0.000175	0.00454	CcSEcCtD
Nandrolone decanoate—Hirsutism—Capecitabine—prostate cancer	0.00017	0.00442	CcSEcCtD
Nandrolone decanoate—Irritability—Ethinyl Estradiol—prostate cancer	0.000168	0.00437	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Mitoxantrone—prostate cancer	0.000168	0.00436	CcSEcCtD
Nandrolone decanoate—AR—lymph node—prostate cancer	0.000167	0.0118	CbGeAlD
Nandrolone decanoate—Erectile dysfunction—Bicalutamide—prostate cancer	0.000166	0.00431	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Goserelin—prostate cancer	0.000166	0.00431	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Conjugated Estrogens—prostate cancer	0.000164	0.00427	CcSEcCtD
Nandrolone decanoate—Hypertension—Abiraterone—prostate cancer	0.000164	0.00427	CcSEcCtD
Nandrolone decanoate—Furunculosis—Epirubicin—prostate cancer	0.000162	0.00421	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Degarelix—prostate cancer	0.000161	0.00418	CcSEcCtD
Nandrolone decanoate—Oedema—Estramustine—prostate cancer	0.00016	0.00416	CcSEcCtD
Nandrolone decanoate—Jaundice—Bicalutamide—prostate cancer	0.000157	0.00407	CcSEcCtD
Nandrolone decanoate—Libido decreased—Goserelin—prostate cancer	0.000156	0.00406	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—SRD5A1—prostate cancer	0.000156	0.0875	CrCbGaD
Nandrolone decanoate—Oedema—Abiraterone—prostate cancer	0.000155	0.00404	CcSEcCtD
Nandrolone decanoate—Oedema—Estrone—prostate cancer	0.000153	0.00397	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Cabazitaxel—prostate cancer	0.000152	0.00394	CcSEcCtD
Nandrolone decanoate—Hirsutism—Prednisone—prostate cancer	0.000151	0.00393	CcSEcCtD
Nandrolone decanoate—MAOA—lymph node—prostate cancer	0.000151	0.0107	CbGeAlD
Nandrolone decanoate—Fluid retention—Estradiol—prostate cancer	0.00015	0.00391	CcSEcCtD
Nandrolone decanoate—Hypertension—Nilutamide—prostate cancer	0.00015	0.0039	CcSEcCtD
Nandrolone decanoate—Furunculosis—Doxorubicin—prostate cancer	0.00015	0.00389	CcSEcCtD
Nandrolone decanoate—Hypertension—Flutamide—prostate cancer	0.00015	0.00388	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Goserelin—prostate cancer	0.000144	0.00374	CcSEcCtD
Nandrolone decanoate—Oedema—Nilutamide—prostate cancer	0.000142	0.00369	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Estradiol—prostate cancer	0.000142	0.00368	CcSEcCtD
Nandrolone decanoate—Oedema—Flutamide—prostate cancer	0.000141	0.00367	CcSEcCtD
Nandrolone decanoate—Furuncle—Epirubicin—prostate cancer	0.00014	0.00365	CcSEcCtD
Nandrolone decanoate—Irritability—Conjugated Estrogens—prostate cancer	0.000137	0.00356	CcSEcCtD
Nandrolone decanoate—Hypertension—Degarelix—prostate cancer	0.000134	0.00349	CcSEcCtD
Nandrolone decanoate—Oedema—Estradiol valerate/Dienogest—prostate cancer	0.000133	0.00347	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Estradiol—prostate cancer	0.000132	0.00342	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Bicalutamide—prostate cancer	0.00013	0.00338	CcSEcCtD
Nandrolone decanoate—Furuncle—Doxorubicin—prostate cancer	0.00013	0.00337	CcSEcCtD
Nandrolone decanoate—Hypertension—Cabazitaxel—prostate cancer	0.000126	0.00328	CcSEcCtD
Nandrolone decanoate—Local reaction—Epirubicin—prostate cancer	0.000124	0.00323	CcSEcCtD
Nandrolone decanoate—Libido decreased—Estradiol—prostate cancer	0.000124	0.00322	CcSEcCtD
Nandrolone decanoate—Urticaria—Estrone—prostate cancer	0.000121	0.00316	CcSEcCtD
Nandrolone decanoate—Dysphonia—Capecitabine—prostate cancer	0.00012	0.00312	CcSEcCtD
Nandrolone decanoate—Oedema—Cabazitaxel—prostate cancer	0.000119	0.0031	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Docetaxel—prostate cancer	0.000116	0.00302	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Goserelin—prostate cancer	0.000115	0.003	CcSEcCtD
Nandrolone decanoate—Local reaction—Doxorubicin—prostate cancer	0.000115	0.00299	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Estradiol—prostate cancer	0.000114	0.00296	CcSEcCtD
Nandrolone decanoate—Pruritus—Estramustine—prostate cancer	0.000113	0.00294	CcSEcCtD
Nandrolone decanoate—Irritability—Estradiol—prostate cancer	0.00011	0.00285	CcSEcCtD
Nandrolone decanoate—Jaundice—Goserelin—prostate cancer	0.000109	0.00283	CcSEcCtD
Nandrolone decanoate—Hypertension—Bicalutamide—prostate cancer	0.000108	0.00282	CcSEcCtD
Nandrolone decanoate—Pruritus—Estrone—prostate cancer	0.000108	0.00281	CcSEcCtD
Nandrolone decanoate—Urticaria—Estradiol valerate/Dienogest—prostate cancer	0.000106	0.00275	CcSEcCtD
Nandrolone decanoate—Acne—Prednisone—prostate cancer	0.000105	0.00272	CcSEcCtD
Nandrolone decanoate—Oedema—Bicalutamide—prostate cancer	0.000102	0.00266	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Epirubicin—prostate cancer	0.000101	0.00262	CcSEcCtD
Nandrolone decanoate—Rash—Estramustine—prostate cancer	0.000101	0.00262	CcSEcCtD
Nandrolone decanoate—Dermatitis—Estramustine—prostate cancer	0.000101	0.00262	CcSEcCtD
Nandrolone decanoate—Urticaria—Degarelix—prostate cancer	0.000101	0.00262	CcSEcCtD
Nandrolone decanoate—Pruritus—Nilutamide—prostate cancer	0.0001	0.00261	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Prednisone—prostate cancer	0.0001	0.0026	CcSEcCtD
Nandrolone decanoate—Pruritus—Flutamide—prostate cancer	0.0001	0.0026	CcSEcCtD
Nandrolone decanoate—Rash—Abiraterone—prostate cancer	9.8e-05	0.00255	CcSEcCtD
Nandrolone decanoate—Dermatitis—Abiraterone—prostate cancer	9.79e-05	0.00254	CcSEcCtD
Nandrolone decanoate—Fluid retention—Docetaxel—prostate cancer	9.69e-05	0.00252	CcSEcCtD
Nandrolone decanoate—Rash—Estrone—prostate cancer	9.64e-05	0.0025	CcSEcCtD
Nandrolone decanoate—Dermatitis—Estrone—prostate cancer	9.63e-05	0.0025	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Epirubicin—prostate cancer	9.55e-05	0.00248	CcSEcCtD
Nandrolone decanoate—Nausea—Estramustine—prostate cancer	9.5e-05	0.00247	CcSEcCtD
Nandrolone decanoate—Pruritus—Estradiol valerate/Dienogest—prostate cancer	9.44e-05	0.00245	CcSEcCtD
Nandrolone decanoate—Fluid retention—Capecitabine—prostate cancer	9.38e-05	0.00244	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Doxorubicin—prostate cancer	9.34e-05	0.00243	CcSEcCtD
Nandrolone decanoate—Nandrolone phenpropionate—AR—prostate cancer	9.16e-05	0.0515	CrCbGaD
Nandrolone decanoate—Nausea—Estrone—prostate cancer	9.08e-05	0.00236	CcSEcCtD
Nandrolone decanoate—Pruritus—Degarelix—prostate cancer	8.97e-05	0.00233	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Conjugated Estrogens—prostate cancer	8.96e-05	0.00233	CcSEcCtD
Nandrolone decanoate—Rash—Nilutamide—prostate cancer	8.95e-05	0.00233	CcSEcCtD
Nandrolone decanoate—Dermatitis—Nilutamide—prostate cancer	8.94e-05	0.00232	CcSEcCtD
Nandrolone decanoate—Rash—Flutamide—prostate cancer	8.91e-05	0.00232	CcSEcCtD
Nandrolone decanoate—Dermatitis—Flutamide—prostate cancer	8.9e-05	0.00231	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Doxorubicin—prostate cancer	8.83e-05	0.0023	CcSEcCtD
Nandrolone decanoate—Oedema—Ethinyl Estradiol—prostate cancer	8.66e-05	0.00225	CcSEcCtD
Nandrolone decanoate—Jaundice—Estradiol—prostate cancer	8.64e-05	0.00224	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Mitoxantrone—prostate cancer	8.53e-05	0.00222	CcSEcCtD
Nandrolone decanoate—Nausea—Nilutamide—prostate cancer	8.43e-05	0.00219	CcSEcCtD
Nandrolone decanoate—Rash—Estradiol valerate/Dienogest—prostate cancer	8.41e-05	0.00219	CcSEcCtD
Nandrolone decanoate—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	8.4e-05	0.00218	CcSEcCtD
Nandrolone decanoate—Nausea—Flutamide—prostate cancer	8.39e-05	0.00218	CcSEcCtD
Nandrolone decanoate—Dysphonia—Epirubicin—prostate cancer	8.36e-05	0.00217	CcSEcCtD
Nandrolone decanoate—Fluid retention—Prednisone—prostate cancer	8.35e-05	0.00217	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Capecitabine—prostate cancer	8.2e-05	0.00213	CcSEcCtD
Nandrolone decanoate—Urticaria—Bicalutamide—prostate cancer	8.14e-05	0.00212	CcSEcCtD
Nandrolone decanoate—Jaundice—Mitoxantrone—prostate cancer	8.05e-05	0.00209	CcSEcCtD
Nandrolone decanoate—Rash—Degarelix—prostate cancer	8e-05	0.00208	CcSEcCtD
Nandrolone decanoate—Dermatitis—Degarelix—prostate cancer	7.99e-05	0.00208	CcSEcCtD
Nandrolone decanoate—Gestodene—CYP3A5—prostate cancer	7.93e-05	0.0447	CrCbGaD
Nandrolone decanoate—Nausea—Estradiol valerate/Dienogest—prostate cancer	7.92e-05	0.00206	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Epirubicin—prostate cancer	7.83e-05	0.00204	CcSEcCtD
Nandrolone decanoate—Testosterone Propionate—CYP17A1—prostate cancer	7.81e-05	0.044	CrCbGaD
Nandrolone decanoate—Dysphonia—Doxorubicin—prostate cancer	7.74e-05	0.00201	CcSEcCtD
Nandrolone decanoate—Libido decreased—Capecitabine—prostate cancer	7.73e-05	0.00201	CcSEcCtD
Nandrolone decanoate—Nandrolone phenpropionate—CYP19A1—prostate cancer	7.66e-05	0.0431	CrCbGaD
Nandrolone decanoate—Hypertension—Goserelin—prostate cancer	7.54e-05	0.00196	CcSEcCtD
Nandrolone decanoate—Nausea—Degarelix—prostate cancer	7.53e-05	0.00196	CcSEcCtD
Nandrolone decanoate—Testosterone—CYP3A43—prostate cancer	7.47e-05	0.042	CrCbGaD
Nandrolone decanoate—Etonogestrel—SHBG—prostate cancer	7.44e-05	0.0419	CrCbGaD
Nandrolone decanoate—Pruritus—Bicalutamide—prostate cancer	7.25e-05	0.00188	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Doxorubicin—prostate cancer	7.25e-05	0.00188	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Estradiol—prostate cancer	7.17e-05	0.00186	CcSEcCtD
Nandrolone decanoate—Oedema—Goserelin—prostate cancer	7.13e-05	0.00185	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Capecitabine—prostate cancer	7.11e-05	0.00185	CcSEcCtD
Nandrolone decanoate—Nausea—Cabazitaxel—prostate cancer	7.1e-05	0.00184	CcSEcCtD
Nandrolone decanoate—Oedema—Conjugated Estrogens—prostate cancer	7.06e-05	0.00183	CcSEcCtD
Nandrolone decanoate—Urticaria—Ethinyl Estradiol—prostate cancer	6.88e-05	0.00179	CcSEcCtD
Nandrolone decanoate—Irritability—Capecitabine—prostate cancer	6.84e-05	0.00178	CcSEcCtD
Nandrolone decanoate—Ethynodiol—ESR1—prostate cancer	6.83e-05	0.0385	CrCbGaD
Nandrolone decanoate—Jaundice—Etoposide—prostate cancer	6.69e-05	0.00174	CcSEcCtD
Nandrolone decanoate—Fluid retention—Epirubicin—prostate cancer	6.53e-05	0.0017	CcSEcCtD
Nandrolone decanoate—Rash—Bicalutamide—prostate cancer	6.46e-05	0.00168	CcSEcCtD
Nandrolone decanoate—Dermatitis—Bicalutamide—prostate cancer	6.46e-05	0.00168	CcSEcCtD
Nandrolone decanoate—Testosterone Propionate—COMT—prostate cancer	6.37e-05	0.0358	CrCbGaD
Nandrolone decanoate—Estradiol valerate/Dienogest—CYP3A4—prostate cancer	6.27e-05	0.0353	CrCbGaD
Nandrolone decanoate—Pruritus—Ethinyl Estradiol—prostate cancer	6.13e-05	0.00159	CcSEcCtD
Nandrolone decanoate—Irritability—Prednisone—prostate cancer	6.1e-05	0.00158	CcSEcCtD
Nandrolone decanoate—Nausea—Bicalutamide—prostate cancer	6.09e-05	0.00158	CcSEcCtD
Nandrolone decanoate—Fluid retention—Doxorubicin—prostate cancer	6.05e-05	0.00157	CcSEcCtD
Nandrolone decanoate—Hypertension—Estradiol—prostate cancer	5.98e-05	0.00155	CcSEcCtD
Nandrolone decanoate—Norgestimate—ESR1—prostate cancer	5.81e-05	0.0327	CrCbGaD
Nandrolone decanoate—Hepatic function abnormal—Epirubicin—prostate cancer	5.72e-05	0.00149	CcSEcCtD
Nandrolone decanoate—Urticaria—Goserelin—prostate cancer	5.66e-05	0.00147	CcSEcCtD
Nandrolone decanoate—Oedema—Estradiol—prostate cancer	5.65e-05	0.00147	CcSEcCtD
Nandrolone decanoate—Urticaria—Conjugated Estrogens—prostate cancer	5.61e-05	0.00146	CcSEcCtD
Nandrolone decanoate—Hypertension—Mitoxantrone—prostate cancer	5.57e-05	0.00145	CcSEcCtD
Nandrolone decanoate—Jaundice—Docetaxel—prostate cancer	5.56e-05	0.00145	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Etoposide—prostate cancer	5.56e-05	0.00144	CcSEcCtD
Nandrolone decanoate—Rash—Ethinyl Estradiol—prostate cancer	5.46e-05	0.00142	CcSEcCtD
Nandrolone decanoate—Dermatitis—Ethinyl Estradiol—prostate cancer	5.46e-05	0.00142	CcSEcCtD
Nandrolone decanoate—Jaundice—Capecitabine—prostate cancer	5.39e-05	0.0014	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Doxorubicin—prostate cancer	5.29e-05	0.00137	CcSEcCtD
Nandrolone decanoate—Oedema—Mitoxantrone—prostate cancer	5.27e-05	0.00137	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—SHBG—prostate cancer	5.26e-05	0.0296	CrCbGaD
Nandrolone decanoate—Nausea—Ethinyl Estradiol—prostate cancer	5.15e-05	0.00134	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Prednisone—prostate cancer	5.08e-05	0.00132	CcSEcCtD
Nandrolone decanoate—Pruritus—Goserelin—prostate cancer	5.04e-05	0.00131	CcSEcCtD
Nandrolone decanoate—Etonogestrel—ESR1—prostate cancer	5.03e-05	0.0283	CrCbGaD
Nandrolone decanoate—Pruritus—Conjugated Estrogens—prostate cancer	5e-05	0.0013	CcSEcCtD
Nandrolone decanoate—Testosterone Propionate—AR—prostate cancer	4.75e-05	0.0267	CrCbGaD
Nandrolone decanoate—Hypertension—Etoposide—prostate cancer	4.63e-05	0.0012	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Docetaxel—prostate cancer	4.62e-05	0.0012	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—AR—prostate cancer	4.62e-05	0.026	CrCbGaD
Nandrolone decanoate—Rash—Goserelin—prostate cancer	4.49e-05	0.00117	CcSEcCtD
Nandrolone decanoate—Dermatitis—Goserelin—prostate cancer	4.49e-05	0.00117	CcSEcCtD
Nandrolone decanoate—Urticaria—Estradiol—prostate cancer	4.49e-05	0.00117	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Capecitabine—prostate cancer	4.47e-05	0.00116	CcSEcCtD
Nandrolone decanoate—Rash—Conjugated Estrogens—prostate cancer	4.45e-05	0.00116	CcSEcCtD
Nandrolone decanoate—Dermatitis—Conjugated Estrogens—prostate cancer	4.45e-05	0.00116	CcSEcCtD
Nandrolone decanoate—Norethindrone—SHBG—prostate cancer	4.27e-05	0.024	CrCbGaD
Nandrolone decanoate—Nausea—Goserelin—prostate cancer	4.23e-05	0.0011	CcSEcCtD
Nandrolone decanoate—Nausea—Conjugated Estrogens—prostate cancer	4.19e-05	0.00109	CcSEcCtD
Nandrolone decanoate—Urticaria—Mitoxantrone—prostate cancer	4.18e-05	0.00109	CcSEcCtD
Nandrolone decanoate—Pruritus—Estradiol—prostate cancer	4e-05	0.00104	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—CYP19A1—prostate cancer	3.86e-05	0.0217	CrCbGaD
Nandrolone decanoate—Hypertension—Docetaxel—prostate cancer	3.85e-05	0.001	CcSEcCtD
Nandrolone decanoate—Jaundice—Epirubicin—prostate cancer	3.75e-05	0.000975	CcSEcCtD
Nandrolone decanoate—Hypertension—Capecitabine—prostate cancer	3.73e-05	0.000969	CcSEcCtD
Nandrolone decanoate—Oedema—Docetaxel—prostate cancer	3.64e-05	0.000946	CcSEcCtD
Nandrolone decanoate—Progesterone—CYP17A1—prostate cancer	3.59e-05	0.0202	CrCbGaD
Nandrolone decanoate—Rash—Estradiol—prostate cancer	3.56e-05	0.000926	CcSEcCtD
Nandrolone decanoate—Dermatitis—Estradiol—prostate cancer	3.56e-05	0.000925	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—ESR1—prostate cancer	3.56e-05	0.02	CrCbGaD
Nandrolone decanoate—Oedema—Capecitabine—prostate cancer	3.52e-05	0.000916	CcSEcCtD
Nandrolone decanoate—Urticaria—Etoposide—prostate cancer	3.48e-05	0.000904	CcSEcCtD
Nandrolone decanoate—Jaundice—Doxorubicin—prostate cancer	3.47e-05	0.000902	CcSEcCtD
Nandrolone decanoate—Progesterone—SLC22A3—prostate cancer	3.42e-05	0.0193	CrCbGaD
Nandrolone decanoate—Norethindrone—CYP3A5—prostate cancer	3.4e-05	0.0191	CrCbGaD
Nandrolone decanoate—Nausea—Estradiol—prostate cancer	3.36e-05	0.000872	CcSEcCtD
Nandrolone decanoate—Hypertension—Prednisone—prostate cancer	3.32e-05	0.000863	CcSEcCtD
Nandrolone decanoate—Rash—Mitoxantrone—prostate cancer	3.32e-05	0.000863	CcSEcCtD
Nandrolone decanoate—Dermatitis—Mitoxantrone—prostate cancer	3.32e-05	0.000862	CcSEcCtD
Nandrolone decanoate—Testosterone—SLC22A3—prostate cancer	3.23e-05	0.0182	CrCbGaD
Nandrolone decanoate—Oedema—Prednisone—prostate cancer	3.14e-05	0.000816	CcSEcCtD
Nandrolone decanoate—Nausea—Mitoxantrone—prostate cancer	3.13e-05	0.000813	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Epirubicin—prostate cancer	3.11e-05	0.000809	CcSEcCtD
Nandrolone decanoate—Pruritus—Etoposide—prostate cancer	3.1e-05	0.000805	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Doxorubicin—prostate cancer	2.88e-05	0.000749	CcSEcCtD
Nandrolone decanoate—Urticaria—Capecitabine—prostate cancer	2.8e-05	0.000728	CcSEcCtD
Nandrolone decanoate—Rash—Etoposide—prostate cancer	2.76e-05	0.000718	CcSEcCtD
Nandrolone decanoate—Dermatitis—Etoposide—prostate cancer	2.76e-05	0.000717	CcSEcCtD
Nandrolone decanoate—Nausea—Etoposide—prostate cancer	2.6e-05	0.000676	CcSEcCtD
Nandrolone decanoate—Hypertension—Epirubicin—prostate cancer	2.6e-05	0.000675	CcSEcCtD
Nandrolone decanoate—Pruritus—Docetaxel—prostate cancer	2.58e-05	0.000669	CcSEcCtD
Nandrolone decanoate—Etonogestrel—CYP3A4—prostate cancer	2.57e-05	0.0144	CrCbGaD
Nandrolone decanoate—Urticaria—Prednisone—prostate cancer	2.49e-05	0.000648	CcSEcCtD
Nandrolone decanoate—Pruritus—Capecitabine—prostate cancer	2.49e-05	0.000648	CcSEcCtD
Nandrolone decanoate—Progesterone—SHBG—prostate cancer	2.49e-05	0.014	CrCbGaD
Nandrolone decanoate—Progesterone—CYP1B1—prostate cancer	2.49e-05	0.014	CrCbGaD
Nandrolone decanoate—Oedema—Epirubicin—prostate cancer	2.46e-05	0.000638	CcSEcCtD
Nandrolone decanoate—Progesterone—SLC22A1—prostate cancer	2.45e-05	0.0138	CrCbGaD
Nandrolone decanoate—Hypertension—Doxorubicin—prostate cancer	2.4e-05	0.000624	CcSEcCtD
Nandrolone decanoate—Testosterone—SHBG—prostate cancer	2.35e-05	0.0132	CrCbGaD
Nandrolone decanoate—Testosterone—CYP1B1—prostate cancer	2.35e-05	0.0132	CrCbGaD
Nandrolone decanoate—Testosterone—SLC22A1—prostate cancer	2.32e-05	0.0131	CrCbGaD
Nandrolone decanoate—Norethindrone—CYP2C19—prostate cancer	2.31e-05	0.013	CrCbGaD
Nandrolone decanoate—Rash—Docetaxel—prostate cancer	2.3e-05	0.000596	CcSEcCtD
Nandrolone decanoate—Dermatitis—Docetaxel—prostate cancer	2.29e-05	0.000596	CcSEcCtD
Nandrolone decanoate—Oedema—Doxorubicin—prostate cancer	2.27e-05	0.00059	CcSEcCtD
Nandrolone decanoate—Rash—Capecitabine—prostate cancer	2.22e-05	0.000577	CcSEcCtD
Nandrolone decanoate—Pruritus—Prednisone—prostate cancer	2.22e-05	0.000577	CcSEcCtD
Nandrolone decanoate—Dermatitis—Capecitabine—prostate cancer	2.22e-05	0.000577	CcSEcCtD
Nandrolone decanoate—Progesterone—AR—prostate cancer	2.18e-05	0.0123	CrCbGaD
Nandrolone decanoate—Nausea—Docetaxel—prostate cancer	2.16e-05	0.000562	CcSEcCtD
Nandrolone decanoate—Nausea—Capecitabine—prostate cancer	2.09e-05	0.000544	CcSEcCtD
Nandrolone decanoate—Testosterone—AR—prostate cancer	2.06e-05	0.0116	CrCbGaD
Nandrolone decanoate—Progesterone—CYP3A5—prostate cancer	1.98e-05	0.0111	CrCbGaD
Nandrolone decanoate—Rash—Prednisone—prostate cancer	1.98e-05	0.000514	CcSEcCtD
Nandrolone decanoate—Dermatitis—Prednisone—prostate cancer	1.98e-05	0.000514	CcSEcCtD
Nandrolone decanoate—Urticaria—Epirubicin—prostate cancer	1.95e-05	0.000507	CcSEcCtD
Nandrolone decanoate—Progesterone—CYP2A6—prostate cancer	1.92e-05	0.0108	CrCbGaD
Nandrolone decanoate—Testosterone—CYP3A5—prostate cancer	1.87e-05	0.0105	CrCbGaD
Nandrolone decanoate—Nausea—Prednisone—prostate cancer	1.86e-05	0.000485	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—CYP3A4—prostate cancer	1.81e-05	0.0102	CrCbGaD
Nandrolone decanoate—Urticaria—Doxorubicin—prostate cancer	1.8e-05	0.000469	CcSEcCtD
Nandrolone decanoate—Pruritus—Epirubicin—prostate cancer	1.74e-05	0.000451	CcSEcCtD
Nandrolone decanoate—Testosterone—CYP19A1—prostate cancer	1.72e-05	0.00971	CrCbGaD
Nandrolone decanoate—Progesterone—ESR1—prostate cancer	1.68e-05	0.00945	CrCbGaD
Nandrolone decanoate—Pruritus—Doxorubicin—prostate cancer	1.61e-05	0.000418	CcSEcCtD
Nandrolone decanoate—Rash—Epirubicin—prostate cancer	1.55e-05	0.000402	CcSEcCtD
Nandrolone decanoate—Dermatitis—Epirubicin—prostate cancer	1.55e-05	0.000402	CcSEcCtD
Nandrolone decanoate—Progesterone—NR3C1—prostate cancer	1.48e-05	0.00832	CrCbGaD
Nandrolone decanoate—Norethindrone—CYP3A4—prostate cancer	1.47e-05	0.00828	CrCbGaD
Nandrolone decanoate—Nausea—Epirubicin—prostate cancer	1.46e-05	0.000379	CcSEcCtD
Nandrolone decanoate—Rash—Doxorubicin—prostate cancer	1.43e-05	0.000372	CcSEcCtD
Nandrolone decanoate—Dermatitis—Doxorubicin—prostate cancer	1.43e-05	0.000372	CcSEcCtD
Nandrolone decanoate—Nausea—Doxorubicin—prostate cancer	1.35e-05	0.000351	CcSEcCtD
Nandrolone decanoate—Progesterone—CYP2C19—prostate cancer	1.35e-05	0.00758	CrCbGaD
Nandrolone decanoate—Progesterone—CYP1A1—prostate cancer	1.34e-05	0.00756	CrCbGaD
Nandrolone decanoate—Testosterone—CYP2C19—prostate cancer	1.27e-05	0.00717	CrCbGaD
Nandrolone decanoate—Testosterone—CYP1A1—prostate cancer	1.27e-05	0.00714	CrCbGaD
Nandrolone decanoate—Progesterone—CYP3A4—prostate cancer	8.57e-06	0.00482	CrCbGaD
Nandrolone decanoate—Testosterone—CYP3A4—prostate cancer	8.1e-06	0.00456	CrCbGaD
Nandrolone decanoate—AR—Gene Expression—RPL10—prostate cancer	7.26e-06	0.000196	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	7.17e-06	0.000194	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SULT1E1—prostate cancer	7.15e-06	0.000193	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SRD5A1—prostate cancer	7.15e-06	0.000193	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—HIST1H2BG—prostate cancer	7.13e-06	0.000193	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	7.08e-06	0.000191	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NCOA3—prostate cancer	7.07e-06	0.000191	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ACSL4—prostate cancer	6.99e-06	0.000189	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HSD17B3—prostate cancer	6.99e-06	0.000189	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	6.94e-06	0.000188	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NPPA—prostate cancer	6.88e-06	0.000186	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—HIST1H4H—prostate cancer	6.88e-06	0.000186	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—PPARA—prostate cancer	6.87e-06	0.000186	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	6.84e-06	0.000185	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ACSL4—prostate cancer	6.82e-06	0.000184	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HSD17B3—prostate cancer	6.82e-06	0.000184	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MED12—prostate cancer	6.77e-06	0.000183	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MYC—prostate cancer	6.77e-06	0.000183	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—HPGDS—prostate cancer	6.75e-06	0.000182	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP2C19—prostate cancer	6.71e-06	0.000181	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PHGDH—prostate cancer	6.7e-06	0.000181	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—UMPS—prostate cancer	6.7e-06	0.000181	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ARG2—prostate cancer	6.7e-06	0.000181	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—prostate cancer	6.62e-06	0.000179	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—LDHB—prostate cancer	6.57e-06	0.000178	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ACHE—prostate cancer	6.54e-06	0.000177	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTT1—prostate cancer	6.54e-06	0.000177	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—UMPS—prostate cancer	6.54e-06	0.000177	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ARG2—prostate cancer	6.54e-06	0.000177	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PHGDH—prostate cancer	6.54e-06	0.000177	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	6.51e-06	0.000176	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	6.5e-06	0.000176	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	6.5e-06	0.000176	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP2A6—prostate cancer	6.47e-06	0.000175	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TP53—prostate cancer	6.46e-06	0.000174	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP3A5—prostate cancer	6.45e-06	0.000174	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—LDHB—prostate cancer	6.41e-06	0.000173	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	6.37e-06	0.000172	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—AKR1C3—prostate cancer	6.29e-06	0.00017	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP3A5—prostate cancer	6.29e-06	0.00017	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PRKACB—prostate cancer	6.26e-06	0.000169	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—prostate cancer	6.25e-06	0.000169	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TCN2—prostate cancer	6.23e-06	0.000168	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—UCP3—prostate cancer	6.23e-06	0.000168	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTA3—prostate cancer	6.23e-06	0.000168	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PDHA1—prostate cancer	6.23e-06	0.000168	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—ESR1—prostate cancer	6.22e-06	0.000168	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP17A1—prostate cancer	6.2e-06	0.000167	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PDHA1—prostate cancer	6.08e-06	0.000164	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TCN2—prostate cancer	6.08e-06	0.000164	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTA3—prostate cancer	6.08e-06	0.000164	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—UCP3—prostate cancer	6.08e-06	0.000164	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—MDM2—prostate cancer	6.07e-06	0.000164	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	6.02e-06	0.000163	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC22A3—prostate cancer	5.94e-06	0.000161	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HSD3B1—prostate cancer	5.94e-06	0.000161	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NCOA2—prostate cancer	5.9e-06	0.00016	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC22A3—prostate cancer	5.8e-06	0.000157	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HSD3B1—prostate cancer	5.8e-06	0.000157	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL6—prostate cancer	5.76e-06	0.000156	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—RPS19—prostate cancer	5.76e-06	0.000156	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTA4—prostate cancer	5.7e-06	0.000154	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TBXAS1—prostate cancer	5.7e-06	0.000154	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SLC5A5—prostate cancer	5.63e-06	0.000152	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	5.62e-06	0.000152	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTA4—prostate cancer	5.56e-06	0.00015	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TBXAS1—prostate cancer	5.56e-06	0.00015	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TP53—prostate cancer	5.56e-06	0.00015	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTA2—prostate cancer	5.55e-06	0.00015	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	5.53e-06	0.000149	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—DNMT1—prostate cancer	5.5e-06	0.000149	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP2E1—prostate cancer	5.5e-06	0.000149	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SULT1A1—prostate cancer	5.48e-06	0.000148	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ABCG5—prostate cancer	5.48e-06	0.000148	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—CREBBP—prostate cancer	5.45e-06	0.000147	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—AKT1—prostate cancer	5.45e-06	0.000147	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NQO1—prostate cancer	5.44e-06	0.000147	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	5.43e-06	0.000147	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTA2—prostate cancer	5.42e-06	0.000146	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NCOA2—prostate cancer	5.4e-06	0.000146	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—TH—prostate cancer	5.36e-06	0.000145	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTA1—prostate cancer	5.36e-06	0.000145	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	5.35e-06	0.000145	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SULT1A1—prostate cancer	5.35e-06	0.000145	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ABCG5—prostate cancer	5.35e-06	0.000145	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—EZH2—prostate cancer	5.33e-06	0.000144	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP3A4—prostate cancer	5.3e-06	0.000143	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HSD3B2—prostate cancer	5.3e-06	0.000143	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTO1—prostate cancer	5.3e-06	0.000143	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NAT2—prostate cancer	5.3e-06	0.000143	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTA1—prostate cancer	5.22e-06	0.000141	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PARP1—prostate cancer	5.22e-06	0.000141	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP1B1—prostate cancer	5.21e-06	0.000141	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HSD3B2—prostate cancer	5.17e-06	0.00014	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NAT2—prostate cancer	5.17e-06	0.00014	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTO1—prostate cancer	5.17e-06	0.00014	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—SERPINE1—prostate cancer	5.11e-06	0.000138	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL6—prostate cancer	5.08e-06	0.000137	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PLCB2—prostate cancer	5.08e-06	0.000137	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—LRP2—prostate cancer	5.08e-06	0.000137	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP2C18—prostate cancer	5.08e-06	0.000137	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GGT1—prostate cancer	5.05e-06	0.000136	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—P4HB—prostate cancer	4.98e-06	0.000135	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NCOA1—prostate cancer	4.97e-06	0.000134	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	4.97e-06	0.000134	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PLCB2—prostate cancer	4.95e-06	0.000134	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—LRP2—prostate cancer	4.95e-06	0.000134	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP2C18—prostate cancer	4.95e-06	0.000134	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—HSPA1A—prostate cancer	4.94e-06	0.000133	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ESR2—prostate cancer	4.94e-06	0.000133	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP19A1—prostate cancer	4.9e-06	0.000132	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—P4HB—prostate cancer	4.86e-06	0.000131	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC22A1—prostate cancer	4.84e-06	0.000131	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—RXRA—prostate cancer	4.73e-06	0.000128	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC22A1—prostate cancer	4.72e-06	0.000128	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SULT2A1—prostate cancer	4.72e-06	0.000128	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—prostate cancer	4.69e-06	0.000127	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	4.67e-06	0.000126	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—MED12—prostate cancer	4.64e-06	0.000125	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GNG5—prostate cancer	4.61e-06	0.000125	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SULT2A1—prostate cancer	4.6e-06	0.000124	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—COMT—prostate cancer	4.56e-06	0.000123	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NCOA1—prostate cancer	4.55e-06	0.000123	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTP1—prostate cancer	4.54e-06	0.000123	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—MED12—prostate cancer	4.53e-06	0.000122	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	4.52e-06	0.000122	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GNG5—prostate cancer	4.49e-06	0.000121	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ITPR1—prostate cancer	4.46e-06	0.000121	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NCOA3—prostate cancer	4.44e-06	0.00012	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NCOA3—prostate cancer	4.33e-06	0.000117	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—RXRA—prostate cancer	4.33e-06	0.000117	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.25e-06	0.000115	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HPGDS—prostate cancer	4.23e-06	0.000114	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—TYMS—prostate cancer	4.22e-06	0.000114	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP2C19—prostate cancer	4.21e-06	0.000114	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTM1—prostate cancer	4.17e-06	0.000113	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HPGDS—prostate cancer	4.13e-06	0.000112	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTT1—prostate cancer	4.11e-06	0.000111	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ACHE—prostate cancer	4.11e-06	0.000111	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP2C19—prostate cancer	4.1e-06	0.000111	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—LPL—prostate cancer	4.09e-06	0.000111	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP2A6—prostate cancer	4.06e-06	0.00011	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ACHE—prostate cancer	4.01e-06	0.000108	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTT1—prostate cancer	4.01e-06	0.000108	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—SIRT1—prostate cancer	3.98e-06	0.000107	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP2A6—prostate cancer	3.96e-06	0.000107	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP1A1—prostate cancer	3.95e-06	0.000107	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—AKR1C3—prostate cancer	3.95e-06	0.000107	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.94e-06	0.000107	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PRKACB—prostate cancer	3.93e-06	0.000106	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—VDR—prostate cancer	3.92e-06	0.000106	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ERCC2—prostate cancer	3.92e-06	0.000106	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP17A1—prostate cancer	3.89e-06	0.000105	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—AKR1C3—prostate cancer	3.85e-06	0.000104	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PRKACB—prostate cancer	3.83e-06	0.000104	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP17A1—prostate cancer	3.79e-06	0.000102	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.74e-06	0.000101	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NCOA2—prostate cancer	3.7e-06	0.0001	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—MTHFR—prostate cancer	3.68e-06	9.96e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PPARA—prostate cancer	3.61e-06	9.77e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NCOA2—prostate cancer	3.61e-06	9.76e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ERCC2—prostate cancer	3.59e-06	9.69e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC5A5—prostate cancer	3.53e-06	9.55e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NR3C1—prostate cancer	3.53e-06	9.53e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP2E1—prostate cancer	3.45e-06	9.33e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC5A5—prostate cancer	3.45e-06	9.31e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NQO1—prostate cancer	3.41e-06	9.22e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CAV1—prostate cancer	3.4e-06	9.18e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP2E1—prostate cancer	3.37e-06	9.1e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TH—prostate cancer	3.36e-06	9.09e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NQO1—prostate cancer	3.33e-06	9e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP3A4—prostate cancer	3.33e-06	8.99e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PPARA—prostate cancer	3.31e-06	8.93e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TH—prostate cancer	3.28e-06	8.87e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP1B1—prostate cancer	3.27e-06	8.84e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.26e-06	8.81e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP3A4—prostate cancer	3.25e-06	8.77e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—MYC—prostate cancer	3.24e-06	8.74e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.23e-06	8.73e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP1B1—prostate cancer	3.19e-06	8.62e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GGT1—prostate cancer	3.17e-06	8.56e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NCOA1—prostate cancer	3.12e-06	8.44e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CG—prostate cancer	3.1e-06	8.36e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GGT1—prostate cancer	3.09e-06	8.35e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP19A1—prostate cancer	3.08e-06	8.31e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NCOA1—prostate cancer	3.04e-06	8.23e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ESR1—prostate cancer	3e-06	8.09e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—RXRA—prostate cancer	2.97e-06	8.02e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—INS—prostate cancer	2.93e-06	7.92e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—RXRA—prostate cancer	2.9e-06	7.83e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CREBBP—prostate cancer	2.87e-06	7.76e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—COMT—prostate cancer	2.86e-06	7.73e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTP1—prostate cancer	2.85e-06	7.69e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.82e-06	7.61e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ITPR1—prostate cancer	2.8e-06	7.57e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—COMT—prostate cancer	2.79e-06	7.54e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTP1—prostate cancer	2.78e-06	7.5e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ITPR1—prostate cancer	2.73e-06	7.38e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CD—prostate cancer	2.72e-06	7.35e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.69e-06	7.26e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TYMS—prostate cancer	2.65e-06	7.15e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—CREBBP—prostate cancer	2.63e-06	7.09e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTM1—prostate cancer	2.62e-06	7.07e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TYMS—prostate cancer	2.58e-06	6.97e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NOS3—prostate cancer	2.57e-06	6.94e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—LPL—prostate cancer	2.57e-06	6.94e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTM1—prostate cancer	2.55e-06	6.89e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—LPL—prostate cancer	2.5e-06	6.77e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP1A1—prostate cancer	2.48e-06	6.7e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—SERPINE1—prostate cancer	2.46e-06	6.65e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ERCC2—prostate cancer	2.46e-06	6.65e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP1A1—prostate cancer	2.42e-06	6.54e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ERCC2—prostate cancer	2.4e-06	6.48e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CB—prostate cancer	2.37e-06	6.41e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTGS2—prostate cancer	2.35e-06	6.35e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—MTHFR—prostate cancer	2.31e-06	6.25e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PPARA—prostate cancer	2.27e-06	6.13e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—MTHFR—prostate cancer	2.25e-06	6.09e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PPARA—prostate cancer	2.21e-06	5.98e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CAV1—prostate cancer	2.13e-06	5.76e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CAV1—prostate cancer	2.08e-06	5.62e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTEN—prostate cancer	2.05e-06	5.54e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.99e-06	5.37e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—EP300—prostate cancer	1.95e-06	5.28e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CG—prostate cancer	1.94e-06	5.25e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CG—prostate cancer	1.89e-06	5.12e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—INS—prostate cancer	1.84e-06	4.97e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CREBBP—prostate cancer	1.8e-06	4.87e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—INS—prostate cancer	1.79e-06	4.85e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CREBBP—prostate cancer	1.76e-06	4.75e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CD—prostate cancer	1.71e-06	4.61e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CD—prostate cancer	1.67e-06	4.5e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NOS3—prostate cancer	1.61e-06	4.36e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NOS3—prostate cancer	1.57e-06	4.25e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MYC—prostate cancer	1.56e-06	4.21e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CB—prostate cancer	1.49e-06	4.02e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTGS2—prostate cancer	1.47e-06	3.99e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CB—prostate cancer	1.45e-06	3.92e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CA—prostate cancer	1.45e-06	3.91e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTGS2—prostate cancer	1.44e-06	3.89e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTEN—prostate cancer	1.29e-06	3.48e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTEN—prostate cancer	1.25e-06	3.39e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—EP300—prostate cancer	1.23e-06	3.31e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—EP300—prostate cancer	1.2e-06	3.23e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—AKT1—prostate cancer	1.18e-06	3.19e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—AKT1—prostate cancer	1.08e-06	2.92e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CA—prostate cancer	9.07e-07	2.45e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CA—prostate cancer	8.85e-07	2.39e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—AKT1—prostate cancer	7.41e-07	2e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—AKT1—prostate cancer	7.23e-07	1.95e-05	CbGpPWpGaD
